This inventor holds 2 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignees: Tianjin Chase Sun Pharmaceutical Co., Ltd, The First Affiliated Hospital, Third Military Medical University, Pla, The First Affiliated Hospital, Third Military University, Pla. Active years: 2016-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 7 
1 out of 1 
1 out of 1 Years Active: 2016-2018
Title: Yongling Lu: Innovator in Pharmaceutical Development
Introduction
Yongling Lu is a prominent inventor based in Chongqing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the prevention and treatment of sepsis and autoimmune diseases. With a total of 2 patents, his work focuses on utilizing traditional Chinese medicine to develop effective drug formulations.
Latest Patents
Yongling Lu's latest patents include the use of Kukoamine A and Kukoamine B in drug preparation. This patent discloses a method for targeting bacterial endotoxin and unmethylated DNA, which are major contributors to sepsis and autoimmune diseases. By isolating lead compounds from traditional Chinese medicine, his approach addresses the uncertainties associated with pharmacological material and drug targets. This innovation aims to create safe and effective drugs for clinical use.
Another significant patent involves the salts of Kukoamine B, detailing their preparation method and pharmaceutical applications. Experimental results indicate that these salts effectively counteract key factors inducing sepsis. This patent provides a new avenue for developing medicinal formulations that can be used in clinical settings, addressing the current lack of effective treatments for sepsis.
Career Highlights
Yongling Lu has worked with notable organizations, including Tianjin Chase Sun Pharmaceutical Co., Ltd and The First Affiliated Hospital, Third Military Medical University. His experience in these institutions has contributed to his expertise in pharmaceutical development and research.
Collaborations
Yongling Lu has collaborated with esteemed colleagues such as Jiang Zheng and Xin Liu. These partnerships have enhanced his research efforts and contributed to the advancement of his innovative projects.
Conclusion
Yongling Lu's contributions to pharmaceutical innovation, particularly in the treatment of sepsis and autoimmune diseases, highlight his role as a key inventor in the field. His patents reflect a commitment to developing effective and safe drug formulations that can significantly impact clinical practices.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile